|
Introduction of production process of phenylacetic acid by oxo synthesis;
|
|
|
羰基合成法生产苯乙酸工艺介绍 |
|
Improvement for the Technology of Pivalic Acid by Koch Carbonylation;
|
|
|
羰基合成特戊酸工艺技术改进 |
|
Rat model of diabetes mellitus and the changes of PPARγ and GLUT-4 expressions in adipose tissue;
|
|
|
糖尿病大鼠模型建立及其脂肪组织PPARγ和GLUT-4表达的改变 |
|
Expressions of hypoxia-inducible factor-1α and vascular endothelial growth factor in retina of streptozotocin-induced diabetic rats;
|
|
|
糖尿病大鼠视网膜缺氧诱导因子-1α和血管内皮生长因子的表达 |
|
Diabetes Clinical study of co-infection;
|
|
|
糖尿病合并感染的临床探讨 |
|
Alterations of Interstitial Cells of Cajal and Stem Cell Factor in Diabetic Colon Dysmotility and the Interventional Effect of Insulin;
|
|
|
糖尿病结肠动力障碍时Cajal间质细胞和干细胞因子的变化以及胰岛素的干预效应 |
|
Efficacy and pharmacoeconomical evaluation of therapeutic regimens for diabetic nephrosis;
|
|
|
糖尿病肾病不同药物治疗方案的疗效观察及经济学评价 |
|
Study of differentiation of monocyte-derived dendritic cell in diabetes nephropathy;
|
|
|
糖尿病肾病患者外周血单核细胞向树突状细胞分化能力的研究 |
|
The Change of Plasma Vascular Endothelial Growth Factor Level in Patients with Diabetic Nephropathies and Intervention Study;
|
|
|
糖尿病肾病患者血浆血管内皮生长因子变化及其干预研究 |
|
Early diagnosis and treatment fordiabetic nephropathy;
|
|
|
糖尿病肾病早期诊断和治疗 |
|
Clinical Analysis in Diabetes Mellitus(DM) and Coronary Artery Disease(CHD);
|
|
|
糖尿病与冠心病关系的临床分析 |
